Market Alert: ASX200 at Critical Support – Reversal or Further Fall?
Micro-X Ltd (ASX: MX1) announces a significant achievement in its commitment to innovation. The Company has successfully secured a Research & Development Tax Incentive of AU$5.83 million for the financial year ending 30 June 2024, alongside an additional AU$0.58 million due to an amendment related to the FY22 R&D tax incentive. This brings the total amount received to AU$6.41 million, consistent with Micro-X's prior guidance.
This substantial cash rebate from the Australian Tax Office underscores its dedication to advancing eligible Australian R&D activities in the 2023/2024 and 2021/2022 financial years. Furthermore, it is important to highlight that Micro-X had previously accessed AU$4.57 million through an advance funding facility, which will be repaid as part of this receipt. This funding reflects its continuous drive for excellence in cold cathode X-ray technology, reinforcing its position as a leader in the health and security markets globally.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 16, 2025
Apr 15, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.